Telangana IT Minister KTR who is currently in US tour, has succeeded in convincing the Multinational pharma company JLabs to set up its unit in Hyderabad. Melinda Richter, Head of JLabs, disclosed it to KTR at a meeting held in the US.
“The Telangana Government has entered into an MoU with J&J towards making the State TB-free. The New Jersey-based Johnson & Johnson will play an active role in the project by assisting the State government in achieving the goal,’’ an official release said.
KTR also met Sanat Chattopadhyay, Executive VP and President, Merck Manufacturing Division, in which the latter expressed Merck’s intent for a social partnership with the Telangana Government on arresting infant diarrhoea.
Even Merck expressed interest in setting up manufacturing base in Telangana in collaboration with the local partners. “Merck has also expressed interest in setting up vaccine centre of excellence in Telangana capital which will also be used for imparting skills, providing training based on the specific requirement of the companies.’’